+1 877 705 191424 / 7
HIPAA Compliant
ISO 27001 Certified

Completed

Phase 2
MALE
ID00000189

Gepirone vs Placebo in Treatment of Cocaine Dependence

Led by University of Pennsylvania · Updated on 2015-05-28

41

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

Sponsors

U

University of Pennsylvania

Lead Sponsor

N

National Institute on Drug Abuse (NIDA)

Collaborating Sponsor

AI-Summary

What this Trial Is About

The purpose of this study is to test antidepressant medication, gepirone, as a pharmacotherapy for cocaine dependent subjects.

CONDITIONS

Brief Title

Gepirone vs Placebo in Treatment of Cocaine Dependence - 3

Who Can Participate

MALE

Eligibility Criteria

Please contact site for information.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here